Skip to content
Smart Spins

The Zimbabwean Government Declines ‘One-Sided’ American Healthcare Assistance Package Because of Information Concerns

Health funding image
The offered American financial assistance was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) spanning five years over Washington's insistence on sensitive data.

This rejection came to light after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "skewed".

A government spokesman has since clarified that the US was demanding access to health data for research and commercial purposes while refused to guarantee the benefits from any future medical innovations.

"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for more dialogue to reach a deal acceptable to both sides so the nation's critical HIV programme can continue.

Wider Context

This rejection follows a similar case in Kenya, where a court halted a similar deal with the US following concerns were raised about the safety of Kenyans' health data.

Since returning to office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

USAID had administered aid for the US government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral agreements to boost transparency and accountability.

According to statements, Sixteen African countries have to date agreed to these new health pacts, constituting over $18.3bn in new funding.

Specifics of the Declined Deal

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"Our nation was requested to provide its genetic material and health information indefinitely, with no corresponding assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," he stated.

"Put simply, our nation would supply the raw materials for scientific discovery without any certainty that the end products would be available to our citizens should a future health crisis emerge."

Sovereignty and Global Health

Mangwana further said that the American exit from the global health body and its push of bilateral health agreements were undermining frameworks previously established via the global health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with future pandemics.

"This framework is designed to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to develop them."

These objections regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.

"We welcome further dialogue with our American counterparts on how future co-operation could be structured in a way that honours the sovereignty and interests of both nations."

Health Experts Reaction

A leading public health body stated it recognised the official position, but urged that negotiations need to persist since a large portion of the nation's Aids initiatives relied on foreign aid.

"Where specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," it said.

This impasse highlights the complex challenges between accepting much-needed international aid and protecting local interests in an ever more interconnected world.

By

Amy Smith

Elara Vance is a tech strategist with over a decade of experience in digital innovation and business transformation, helping companies adapt to emerging technologies.

Smart Spins

Type to search articles.